NX-125

N/A

Report date: 2025/01/26 15:34:23
NME

Base Information

Drug NameNX-125
Drug Alias Nameboxitinibboxitinib hydrochloride (HEC Pharm)NX-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHec Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHec Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A